HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spontaneous improvement of juvenile rheumatoid arthritis after T lymphocytosis with suppressor phenotype and function.

Abstract
Spontaneous improvement of active juvenile rheumatoid arthritis (JRA) occurred after T lymphocytosis in an 8-year-old boy. He had prominent lymphocytosis, the count reaching 59,000/mm3, followed by spontaneous disappearance of fever, arthralgia, lymphadenopathy, hepatomegaly, and C-reactive protein. The serum immunoglobulin levels were gradually decreased. The surface marker analysis, using two color flow cytometry, showed that the lymphocytes were activated suppressor T lymphocytes, expressing CD3, CD8, HLA-DR, and CD8 plus CD11. When studied in vitro with pokeweed mitogen stimulation, the T lymphocytes significantly suppressed the immunoglobulin production by autologous B lymphocytes as compared with the T lymphocytes at remission (p less than 0.01). Based on the widely believed notion that depression of suppressor T lymphocyte functions is one of the important mechanisms underlying systemic JRA, the activated T lymphocytosis with the suppressor phenotype and suppressive function on the immunoglobulin production may have been related to the improvement of active JRA in the patient.
AuthorsM Ichikawa, M Yanagisawa, H Kawai, T Kamijo, A Komiyama, T Akabane
JournalJournal of clinical & laboratory immunology (J Clin Lab Immunol) Vol. 27 Issue 4 Pg. 197-201 (Dec 1988) ISSN: 0141-2760 [Print] Scotland
PMID2977987 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Differentiation, T-Lymphocyte
  • Immunoglobulins
Topics
  • Antigens, Differentiation, T-Lymphocyte
  • Arthritis, Juvenile (complications, immunology)
  • B-Lymphocytes (immunology)
  • Child
  • Humans
  • Immunoglobulins (biosynthesis)
  • In Vitro Techniques
  • Lymphocytosis (complications, immunology)
  • Male
  • Phenotype
  • Remission, Spontaneous
  • T-Lymphocytes, Regulatory (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: